11 completed. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 11 |
Follow Blepharitis: new trials by email Literature Review of Blepharitis trials Research Report on Blepharitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Demodex Blepharitis in Scleral Lens Wearers Xdemvy - Demodex Blepharitis | Phase 4 | Completed | Boston Sight | 6 | 2026-04-27 | 2026-10-22 |
| Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation Moxidectin 2 MG Oral Tablet, Placebo - Blepharitis | Phase 4 | Completed | Eye Research Foundation, Inc. | 24 | 2025-02-02 | 2025-08-12 |
| Treatment of Blepharitis Induced by Demodex Folliculorum Through Eyelid Cleansing With Wipes Containing Topical Chlorhexidine Eyelid Cleansing with Wipes Containing Topical Chlorhexidine - Blepharitis | Phase 4 | Completed | Instituto de Oftalmología Fundación Conde de Valenciana | 39 | 2024-07-01 | 2026-07-08 |
| Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis Loteprednol/tobramycin, Loteprednol, B+L Advanced Eye Relief Lubricant Drop - Meibomian Gland Dysfunction, Posterior Blepharitis | Phase 4 | Completed | Massachusetts Eye and Ear Infirmary | 60 | 2011-08-01 | 2017-08-01 |
| Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis Erythromycin, Besifloxocin - Blepharitis | Phase 4 | Completed | John, George, M.D. | 30 | 2011-08-01 | 2013-12-19 |
| Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis Posiformin 2 %, bibrocathol, Placebo Comparator - Blepharitis, Signs and Symptoms | Phase 4 | Completed | Ursapharm Arzneimittel GmbH | 197 | 2009-02-01 | 2011-05-20 |
| Lipids of the Human Tear Film and Their Effect on Tear Stability doxycycline, azithromycin - Blepharitis | Phase 4 | Completed | University of Louisville | 31 | 2008-07-01 | 2017-12-22 |
| Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis AzaSite® - Blepharitis | Phase 4 | Completed | Merck Sharp & Dohme LLC | 20 | 2008-04-01 | 2011-09-26 |
| Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis AzaSite® - Blepharitis | Phase 4 | Completed | Merck Sharp & Dohme LLC | 20 | 2008-03-01 | 2011-09-26 |
| Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis AzaSite® - Blepharitis | Phase 4 | Completed | Merck Sharp & Dohme LLC | 25 | 2008-03-01 | 2011-09-26 |
| Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis AzaSite® - Blepharitis | Phase 4 | Completed | Merck Sharp & Dohme LLC | 60 | 2008-02-01 | 2011-09-26 |
Meibomian Gland Dysfunction (2) · Dry Eye Syndromes (1) · Signs and Symptoms (1)
Eye Diseases (11) · Eyelid Diseases (11) · Lacrimal Apparatus Diseases (1) · Pathological Conditions, Signs and Symptoms (1)
Azithromycin (5) · Doxycycline (1) · Erythromycin (1) · Loteprednol Etabonate (1) · Lubricant Eye Drops (1) · Minocycline (1) · Tablets (1) · Tobramycin (1) · besifloxacin (1) · bibrocathol (1) · moxidectin (1)
Merck Sharp & Dohme LLC (4) · Boston Sight (1) · Eye Research Foundation, Inc. (1) · Instituto de Oftalmología Fundación Conde de Valenciana (1) · John, George, M.D. (1) · Massachusetts Eye and Ear Infirmary (1) · University of Louisville (1) · Ursapharm Arzneimittel GmbH (1)
United States (9) · Mexico (1) · Ukraine (1)
Reza Haque, MD (3) · Daniel Brocks, MD (1) · Gary N Foulks, MD (1) · Pavel A Bezdetko, Prof. (1) · Reza Dana, MD, MPH, MSc (1) · Reza Haque (1)
PMID 20489573, PMID 20689407, PMID 21398284, PMID 22527308, PMID 22668581, PMID 23748846, PMID 24470662, PMID 25902082, PMID 27399954, PMID 28902017, PMID 30120003, PMID 30950926, PMID 31612399, PMID 31806355, PMID 32589270, PMID 32885484, PMID 33972176, PMID 34743107, PMID 35965392, PMID 36875531, PMID 37272680, PMID 37285925